Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06625671
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-20
Brief Title:
A Phase 1 Study of DB-2304 in Healthy Adults
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Randomized Double-Blind Placebo- and Positive-Controlled Single Ascending Dose Phase 1 Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of DB-2304 Injection in Healthy Adult Participants
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A Randomized Double-Blind Placebo- and Positive-Controlled Single Ascending Dose Phase 1 Study to Evaluate the Safety Tolerability and Pharmacokinetics of DB-2304 Injection in Healthy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None